- Previous Close
243.90 - Open
265.80 - Bid 255.00 x --
- Ask 264.25 x --
- Day's Range
247.90 - 268.00 - 52 Week Range
213.50 - 702.25 - Volume
7,310 - Avg. Volume
4,577 - Market Cap (intraday)
3.408B - Beta (5Y Monthly) 0.32
- PE Ratio (TTM)
-- - EPS (TTM)
-104.98 - Earnings Date May 26, 2025 - May 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Kaya Limited owns and operates skin and hair care clinics in India and the Middle East. The company offers skin care products, such as facewash, cleansers, toners, moisturizers, creams, face serums, sunscreens, kits and regimes, and wet wipes; hair care products that include shampoos, hair serums, hair lotions, hair oils, and hair masques; and bath and body products. It also provides skin services comprising laser hair, thermage, HIFU, dermal fillers, chemical peel, Q-switch laser, and skin brightening and lightening treatments; hair services, such as PRP GF treatment, PDO hair thread treatment, biocell hair therapy, intensive hair root therapy, and hair nutri-infusion therapy; and body contouring services consisting of Kaya wonder treatment, CM slim, Venus Legacy, and cool sculpting. The company sells its products through Kaya standalone stores, online, and third-party outlets. Kaya Limited has partnership with Bien-Etre Ltd to develop skin personalization platform using DNA biomarkers and AI. The company was founded in 2002 and is headquartered in Mumbai, India.
www.kaya.in687
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: KAYA.BO
View MorePerformance Overview: KAYA.BO
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: KAYA.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: KAYA.BO
View MoreValuation Measures
Market Cap
3.41B
Enterprise Value
5.44B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.82
Price/Book (mrq)
--
Enterprise Value/Revenue
1.32
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-1.82%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
4.13B
Net Income Avi to Common (ttm)
-1.37B
Diluted EPS (ttm)
-104.98
Balance Sheet and Cash Flow
Total Cash (mrq)
251.24M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--